Masamitsu Onda

Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.

Guo Jun Zhang, Izo Kimijima, Masamitsu Onda et al. · PubMed · 1999 · 159 citations

Breast Oncology, Apoptosis, Cell Death +17

Expression profiling to predict postoperative prognosis for estrogen receptor‐negative breast cancers by analysis of 25,344 genes on a cDNA microarray

Takemitsu Nagahata, Masamitsu Onda, Mitsuru Emi et al. · Cancer Science · 2004 · 120 citations · Full text

Amplification, up‐regulation and over‐expression of <i>DVL‐1</i>, the human counterpart of the <i>Drosophila disheveled</i> gene, in primary breast cancers

Takemitsu Nagahata, Takashi Shimada, Akima Harada et al. · Cancer Science · 2003 · 117 citations · Full text

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

B Iacopetta, Antonio Russo, Viviana Bazan et al. · Annals of Oncology · 2006 · 117 citations · Full text

Functional Categories, Tp53 Mutation, Medicine +9

A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity

Weiping Yu, Issei Imoto, Jun‐ichiro Inoue et al. · Oncogene · 2006 · 102 citations

Signaling Pathway, Medicine, Receptor Tyrosine Kinase +9